Majellano Eleanor C, Yorke Janelle, Clark Vanessa L, Gibson Peter G, Smith Amber J, Holmes Leanne J, McDonald Vanessa M
National Health and Medical Research Council Centre for Research Excellence in Severe Asthma, and Asthma and Breathing Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.
National Health and Medical Research Council Centre for Research Excellence in Treatable Traits, New Lambton Heights, NSW, Australia.
ERJ Open Res. 2024 May 27;10(3). doi: 10.1183/23120541.00864-2023. eCollection 2024 May.
Disabling symptoms of asthma including breathlessness, cough, wheeze and chest tightness largely impact quality of life; however, how these symptoms impact people with asthma of different severity levels remains unknown. This study aimed to compare and characterise patients' symptom experience and the burden caused, their quality of life, and the medication preferences of people with severe asthma against those of people with mild-to-moderate asthma.
This was a multisite qualitative study involving two focus groups and semistructured interviews of adults with severe asthma undertaken in Australia and UK. Interviews were also undertaken in people with mild-to-moderate asthma. Audio recordings were transcribed and analysed thematically.
Participants in both severe asthma and mild-to-moderate asthma groups had a mean±sd age of 57±12 years. Between the severe asthma and mild-to-moderate asthma groups, 62% of participants were female and 86% lived with family. Themes were identified: 1) what is asthma and most bothersome symptoms: both groups reported breathlessness as the most bothersome symptom; 2) impacts on life: disease-related impact differed as people with severe asthma reported significant burden in their quality of life, which encompassed emotional, physical, social and financial wellbeing; and 3) personalised and responsive care: severe asthma interviewees preferred injectable biological therapy as a mode of treatment administration.
People with asthma are burdened by breathlessness and cough and other disabling symptoms resulting in impaired quality of life. Understanding the experiences of people with asthma of different severities can improve the patient-clinician partnership.
哮喘的致残症状,包括呼吸急促、咳嗽、喘息和胸闷,在很大程度上影响生活质量;然而,这些症状如何影响不同严重程度的哮喘患者仍不清楚。本研究旨在比较和描述重度哮喘患者与轻至中度哮喘患者的症状体验、所造成的负担、生活质量以及药物偏好。
这是一项多中心定性研究,在澳大利亚和英国对重度哮喘成年人进行了两个焦点小组和半结构式访谈。也对轻至中度哮喘患者进行了访谈。对录音进行转录并进行主题分析。
重度哮喘组和轻至中度哮喘组参与者的平均年龄±标准差为57±12岁。在重度哮喘组和轻至中度哮喘组中,62%的参与者为女性,86%与家人同住。确定了以下主题:1)什么是哮喘以及最困扰的症状:两组均报告呼吸急促是最困扰的症状;2)对生活的影响:与疾病相关的影响有所不同,因为重度哮喘患者报告其生活质量存在重大负担,包括情绪、身体、社会和经济福祉;3)个性化和响应式护理:重度哮喘受访者更喜欢注射用生物疗法作为治疗给药方式。
哮喘患者因呼吸急促、咳嗽和其他致残症状而负担沉重,导致生活质量受损。了解不同严重程度哮喘患者的经历可以改善医患关系。